Gilead price target raised to $155 from $152 at Truist
Truist analyst Gregory Renza raised the firm’s price target on Gilead (GILD) to $155 from $152 and keeps a Buy…
Tag: Gilead
Gilead to Acquire Ouro Medicines in $2.18B Deal, Expand Inflammation Pipeline
Gilead Sciences, Inc. (NASDAQ:GILD) is included among the Dividend Stock Portfolio for Income: 15 Stocks to Invest In. Gilead to…
‘The Handmaid’s Tale’ Sequel Show is Growing Up Gilead
Bruce Miller has no interest in retreading old The Handmaid’s Tale ground. Over the course of six seasons, the veteran…
UBS Turns More Bullish on Gilead Sciences, Inc. (GILD) Amid Positive Pharma Sector Outlook
Gilead Sciences, Inc. (NASDAQ:GILD) is among the most profitable healthcare stocks to buy. On January 26, UBS lifted the price…
Morgan Stanley Expects Gilead Sciences (GILD) to Thrive as Biopharma Policy Uncertainties Fade in 2026
Gilead Sciences Inc. (NASDAQ:GILD) is one of the best stocks for the next decade. On December 12, Morgan Stanley raised…
Gilead Sciences, Inc. (GILD)’s Mixed Quarter Draws Divergent Analyst Views
Gilead Sciences, Inc. (NASDAQ:GILD) is one of the best blue-chip stocks to buy now. On November 3, Bernstein SocGen Group…
Gilead posts higher profit on demand for HIV drugs, but overall sales dip
By Deena Beasley (Reuters) -Gilead Sciences said on Thursday its HIV drug sales rose 4% to $5.3 billion in the…
Leerink Partners Maintains Buy on Gilead Sciences (GILD)
Gilead Sciences, Inc. (NASDAQ:GILD) is one of the Most Undervalued S&P 500 Stocks to Buy Right Now. On September 2,…
Gilead Acquires Interius BioTherapeutics to Advance Next-Gen Cell Therapy
Gilead Sciences Inc. (NASDAQ:GILD) is one of the best growth stocks to buy for the next 2 years. On August…
Gilead starts building manufacturing hub under $32 billion planned US investments
(Reuters) -Gilead Sciences said on Wednesday it has started work on a new pharmaceutical development and manufacturing hub at its…